Biologic medicine inclusion in 138 national essential medicines lists

BACKGROUND: Essential medicines lists (EMLs) are intended to reflect the priority health care needs of populations. We hypothesized that biologic disease-modifying antirheumatic drugs (DMARDs) are underrepresented relative to conventional DMARDs in existing national EMLs. We aimed to survey the exte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraus, Raphaël, Yeung, Rae S. M., Persaud, Nav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419977/
https://www.ncbi.nlm.nih.gov/pubmed/34488779
http://dx.doi.org/10.1186/s12969-021-00608-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419977/
https://www.ncbi.nlm.nih.gov/pubmed/34488779
http://dx.doi.org/10.1186/s12969-021-00608-z

Ejemplares similares